Market Place
Sourcing Support
All News #Library
Biotech
Protalix Biotherapeutics To Report FY2025 Financials
11 Mar 2026 //
PR NEWSWIRE
Protalix Bio Therapeutics Reports Q2 2025 Financial, Business
14 Aug 2025 //
PR NEWSWIRE
Protalix BioTherapeutics to Announce Q2 2025 Financial Results
08 Aug 2025 //
PR NEWSWIRE
Protalix Bio Names Gilad Mamlok as New Senior VP and CFO
21 Jul 2025 //
PR NEWSWIRE
Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes®
30 Jun 2025 //
PR NEWSWIRE
Protalix BioTherapeutics to Present at H.C. Wainwright BioConnect
14 May 2025 //
PR NEWSWIRE
Protalix BioTherapeutics to Present at iAccess Alpha Virtual Conf
24 Mar 2025 //
PR NEWSWIRE
Protalix BioTherapeutics to Announce FY 2024 Results on March 17
10 Mar 2025 //
PR NEWSWIRE
Protalix Announces First Patient Dosed in First in Human PI Trial of PRX-115
21 Mar 2023 //
PR NEWSWIRE
Protalix & Chiesi gain positive opinion for pegunigalsidase alfa
06 Mar 2023 //
PHARMATIMES
Chiesi & Protalix Receive Positive CHMP Opinion for Pegunigalsidase Alfa
25 Feb 2023 //
BIOSPACE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.